Arch Therapeutics

Arch Therapeutics

Arch Therapeutics

Arch is a medical company offering an innovative and superior approach to the rapid cessation of bleeding and control of fluid leakage during trauma and surgery
Founded
2006
Raised
$7.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$3,400,000
Post-IPO equity - 2016
$3,000,000
Private equity - 2015
Team Size
1–10
Employees
$3,400,000 Post-IPO equity
MassDevice

Arch Therapeutics raises $3.4m to support novel blood control dev

$3,000,000 Private equity
Worcester Business Journal

Arch Therapeutics raises $3M in financing